Haemonetics | HAE - Gewinn Vor Steuern

Aktienkurs
60.15
Täglich Wechseln
1.14 1.93%
Monatlich
6.72%
Jährlich
-4.51%
Q2 Prognose
58.65




Gewinn Vor Steuern Veränderung Datum
Avanos Medical USD -1.2M 74.7M 2025-09
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cerus USD -20.76M 17.9M 2024-12
Cooper Companies USD 116.8M 137.4M 2025-09
Fresenius EUR 601M 122M 2025-12
Fresenius Medical Care EUR 508.46M 105.89M 2025-12
Globus Medical USD 143.99M 44.18M 2025-09
Haemonetics USD 59.97M 8.69M 2025-12
ICU Medical USD 70.3M 36.62M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Neogen USD 28M 15.81M 2025-09
OraSure Technologies USD -18.43M 5.14M 2025-12
Plus Therapeutics USD -5.71M 1.29M 2025-12
Quidel USD -756.9M 527.3M 2025-09
ResMed USD 496.15M 13.77M 2025-12
STAAR Surgical USD 18.79M 44.7M 2025-09
Steris USD 324.4M 92.5M 2025-09
Stryker USD 1.7B 676M 2025-12
Surmodics USD -5.9M 1.61M 2025-06
Teleflex USD -438.58M 573.82M 2025-09
Terumo JPY 45.38B 578M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
US Physical Therapy USD 18.77M 3.88M 2025-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12